Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,842 | 15,299 | 10,631 | 7,940 | 9,014 |
| Marketable Securities | 17,758 | 440 | 798 | N/A | 6,461 |
| Other current assets | 141 | 101 | 74 | 0 | 0 |
| TOTAL | $98,766 | $16,486 | $11,825 | $8,433 | $16,311 |
| Non-Current Assets | |||||
| PPE Net | 334 | 384 | 142 | 213 | 340 |
| Other Non-Current Assets | 1,376 | 0 | 0 | 0 | 0 |
| TOTAL | $1,710 | $384 | $142 | $213 | $340 |
| Total Assets | $100,476 | $16,870 | $11,967 | $8,646 | $16,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,960 | 1,315 | 589 | 1,318 | 409 |
| Accrued Expenses | 3,058 | 1,474 | 1,176 | N/A | 1,437 |
| TOTAL | $5,539 | $2,789 | $1,765 | $1,318 | $1,846 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,011 | 0 | 0 | 0 | 0 |
| TOTAL | $1,011 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,550 | $2,789 | $1,765 | $1,318 | $1,846 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169 | N/A | N/A | 35 | N/A |
| Common Shares | 365,490 | 261,072 | 231,923 | 218,034 | 175,076 |
| Retained earnings | -301,915 | -275,638 | -246,770 | -235,127 | -182,508 |
| Other shareholders' equity | -4,298 | -4,316 | -4,316 | 3,008 | 4,968 |
| TOTAL | $93,926 | $14,081 | $10,202 | $7,328 | $14,805 |
| Total Liabilities And Equity | $100,476 | $16,870 | $11,967 | $8,646 | $16,651 |